Blueprint Medicines Corp (NASDAQ:BPMC)

91.60
Delayed Data
As of 3:59pm ET
 +2.72 / +3.06%
Today’s Change
43.29
Today|||52-Week Range
92.63
+14.34%
Year-to-Date
Blueprint Medicines Rises YTD on Robust Ayvakit Progress
11:46am / Zacks.com - Paid Partner Content
US Indexes Close Higher Tuesday
Sep 23 / GuruFocus News - Paid Partner Content
Blueprint Medicines' Gist Drug Ayvakyt Gets EU Approval
Sep 28 / Zacks.com - Paid Partner Content
Sector Watch: More oncology events as cancer ETF breaks out
Sep 20 / Seeking Alpha - Paid Partner Content
Blueprint Medicines Up on Positive Top-Line Data From SM Study
Sep 23 / Zacks.com - Paid Partner Content
Blueprint Medicines's BLU-945 shows encouraging action in preclinical study in lung cancer
Sep 17 / Seeking Alpha - Paid Partner Content
Biotech Stock Roundup: Bristol-Myers' Updates, VCNX's Disappointing Data & More
Sep 23 / Zacks.com - Paid Partner Content
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
Sep 11 / Seeking Alpha - Paid Partner Content
Company News for Sep 23, 2020
Sep 23 / Zacks.com - Paid Partner Content
Blueprint Receives FDA Approval, And Other News: The Good, Bad And Ugly Of Biopharma
Sep 10 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close88.88
Today’s open89.00
Day’s range88.90 - 92.63
Volume25,158
Average volume (3 months)494,598
Market cap$4.9B
Data as of 3:59pm ET, 09/29/2020

Growth & Valuation

Earnings growth (last year)-34.76%
Earnings growth (this year)+149.00%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+49.39%
P/E ratioNM
Price/Sales57.61
Price/Book9.34

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...+0.38+1.19%
ALLOAllogene Therapeutic...+0.49+1.32%
ARWRArrowhead Pharmaceut...-0.23-0.53%
----
Data as of 3:59pm ET, 09/29/2020

Financials

Next reporting dateNovember 4, 2020
EPS forecast (this quarter)$9.25
Annual revenue (last year)$66.5M
Annual profit (last year)-$347.7M
Net profit margin-522.75%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts